| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Management |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Systematic review with expert consensus on use of extracorporeal hemoadsorption in septic shock: An Indian perspective
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yatin Mehta, Abdul Samad Ansari, Amit Kumar Mandal, Dipanjan Chatterjee, Gauri Shankar Sharma, Prachee Sathe, Purvesh V Umraniya, Rajib Paul, Sachin Gupta, Vinod Singh and Yogendra Pal Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yatin Mehta, DNB, MD, Chairman, Doctor, Institute of Critical Care and Anesthesiology, Medanta The Medicity, Gurgaon 122001, Haryana, India. yatinmehta@hotmail.com |
| Key Words |
Consensus; CytoSorb; Cytokine; Hemoadsorption; Refractory; Sepsis; Septic shock |
| Core Tip |
This evidence-based expert consensus statement gives information/clarity on the key areas of knowledge gaps of CytoSorb® therapy: need for adjuvant therapy, initiation timeline, need for Interleukin -6 levels, duration of therapy, change of adsorbers, safety, prerequisite condition, efficacy endpoints, and (therapy) management flowchart. This expert consensus statements provides general physicians, emergency care physicians, anaesthetist, and intensivists with current information regarding the use of CytoSorb® haemoadsorption as an adjuvant treatment in patients with refractory septic shock. |
| Publish Date |
2024-03-05 06:47 |
| Citation |
Mehta Y, Ansari AS, Mandal AK, Chatterjee D, Sharma GS, Sathe P, Umraniya PV, Paul R, Gupta S, Singh V, Singh YP. Systematic review with expert consensus on use of extracorporeal hemoadsorption in septic shock: An Indian perspective. World J Crit Care Med 2024; 13(1):89026 |
| URL |
https://www.wjgnet.com/2220-3141/full/v13/i1/89026.htm |
| DOI |
10.5492/wjccm.v13.i1.89026 |
